217 related articles for article (PubMed ID: 18686123)
1. Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.
Beck Z; Karasavvas N; Matyas GR; Alving CR
J Drug Target; 2008 Aug; 16(7):535-42. PubMed ID: 18686123
[TBL] [Abstract][Full Text] [Related]
2. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
Karasavvas N; Beck Z; Tong J; Matyas GR; Rao M; McCutchan FE; Michael NL; Alving CR
Biochem Biophys Res Commun; 2008 Feb; 366(4):982-7. PubMed ID: 18088597
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
[TBL] [Abstract][Full Text] [Related]
4. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
Julien JP; Bryson S; Nieva JL; Pai EF
J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
[TBL] [Abstract][Full Text] [Related]
5. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
[TBL] [Abstract][Full Text] [Related]
6. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
Alving CR; Beck Z; Karasavva N; Matyas GR; Rao M
Mol Membr Biol; 2006; 23(6):453-65. PubMed ID: 17127618
[TBL] [Abstract][Full Text] [Related]
7. Lipid A and liposomes containing lipid A as antigens and adjuvants.
Alving CR; Rao M
Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433
[TBL] [Abstract][Full Text] [Related]
8. The immunogenic CBD1 peptide corresponding to the caveolin-1 binding domain in HIV-1 envelope gp41 has the capacity to penetrate the cell membrane and bind caveolin-1.
Benferhat R; Sanchez-Martinez S; Nieva JL; Briand JP; Hovanessian AG
Mol Immunol; 2008 Apr; 45(7):1963-75. PubMed ID: 18054388
[TBL] [Abstract][Full Text] [Related]
9. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies.
Huarte N; Lorizate M; Kunert R; Nieva JL
FEBS Lett; 2008 Nov; 582(27):3798-804. PubMed ID: 18930052
[TBL] [Abstract][Full Text] [Related]
10. Distinct mechanisms of lipid bilayer perturbation induced by peptides derived from the membrane-proximal external region of HIV-1 gp41.
Apellániz B; Nir S; Nieva JL
Biochemistry; 2009 Jun; 48(23):5320-31. PubMed ID: 19449801
[TBL] [Abstract][Full Text] [Related]
11. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
[TBL] [Abstract][Full Text] [Related]
12. Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate.
Beck Z; Karasavvas N; Tong J; Matyas GR; Rao M; Alving CR
Biochem Biophys Res Commun; 2007 Mar; 354(3):747-51. PubMed ID: 17257584
[TBL] [Abstract][Full Text] [Related]
13. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A.
Matyas GR; Alving CR
Vaccine; 2011 Jul; 29(32):5137-44. PubMed ID: 21624414
[TBL] [Abstract][Full Text] [Related]
15. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes.
Benferhat R; Krust B; Rey-Cuillé MA; Hovanessian AG
Vaccine; 2009 Jun; 27(27):3620-30. PubMed ID: 19464543
[TBL] [Abstract][Full Text] [Related]
16. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
[TBL] [Abstract][Full Text] [Related]
17. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
Sánchez-Martínez S; Lorizate M; Hermann K; Kunert R; Basañez G; Nieva JL
FEBS Lett; 2006 Apr; 580(9):2395-99. PubMed ID: 16616522
[TBL] [Abstract][Full Text] [Related]
18. The influence of cholesterol on the interaction of HIV gp41 membrane proximal region-derived peptides with lipid bilayers.
Veiga AS; Castanho MA
FEBS J; 2007 Oct; 274(19):5096-104. PubMed ID: 17803684
[TBL] [Abstract][Full Text] [Related]
19. The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl ceramide, is structure-dependent.
Yu H; Alfsen A; Tudor D; Bomsel M
Cell Calcium; 2008 Jan; 43(1):73-82. PubMed ID: 17553560
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
Buzón V; Cladera J
Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
